Stop the clots, but at what cost? Pharmacoeconomics of dabigatran etexilate for the prevention of stroke in subjects with atrial fibrillation: a systematic literature review
S Marshall, P Fearon, J Dawson… - Expert review of …, 2013 - Taylor & Francis
Dabigatran etexilate is a newly approved agent for prophylaxis of stroke in atrial fibrillation.
Through narrative review, the authors assess evidence of the efficacy of dabigatran in stroke …
Through narrative review, the authors assess evidence of the efficacy of dabigatran in stroke …
Stop the clots, but at what cost? Pharmacoeconomics of dabigatran etexilate for the prevention of stroke in subjects with atrial fibrillation: a systematic literature review
S Marshall, P Fearon, J Dawson… - Expert review of …, 2013 - pubmed.ncbi.nlm.nih.gov
Dabigatran etexilate is a newly approved agent for prophylaxis of stroke in atrial fibrillation.
Through narrative review, the authors assess evidence of the efficacy of dabigatran in stroke …
Through narrative review, the authors assess evidence of the efficacy of dabigatran in stroke …
Stop the clots, but at what cost? Pharmacoeconomics of dabigatran etexilate for the prevention of stroke in subjects with atrial fibrillation: a systematic literature review.
S Marshall, P Fearon, J Dawson… - Expert Review of …, 2013 - europepmc.org
Dabigatran etexilate is a newly approved agent for prophylaxis of stroke in atrial fibrillation.
Through narrative review, the authors assess evidence of the efficacy of dabigatran in stroke …
Through narrative review, the authors assess evidence of the efficacy of dabigatran in stroke …
Stop the clots, but at what cost? Pharmacoeconomics of dabigatran etexilate for the prevention of stroke in subjects with atrial fibrillation: a systematic literature review
S Marshall, P Fearon, J Dawson… - Expert Review of …, 2013 - eprints.gla.ac.uk
Dabigatran etexilate is a newly approved agent for prophylaxis of stroke in atrial fibrillation.
Through narrative review, the authors assess evidence of the efficacy of dabigatran in stroke …
Through narrative review, the authors assess evidence of the efficacy of dabigatran in stroke …
Stop the clots, but at what cost? Pharmacoeconomics of dabigatran etexilate for the prevention of stroke in subjects with atrial fibrillation: a systematic literature review
S Marshall, P Fearon, J Dawson… - Expert Review of …, 2013 - search.proquest.com
Dabigatran etexilate is a newly approved agent for prophylaxis of stroke in atrial fibrillation.
Through narrative review, the authors assess evidence of the efficacy of dabigatran in stroke …
Through narrative review, the authors assess evidence of the efficacy of dabigatran in stroke …
Stop the clots, but at what cost? Pharmacoeconomics of dabigatran etexilate for the prevention of stroke in subjects with atrial fibrillation: a systematic literature review
S Marshall, P Fearon, J Dawson… - Expert Review of …, 2013 - go.gale.com
Stroke related to atrial fibrillation (AF)/flutter is a common cause of morbidity and mortality
with substantial associated cost. A low-cost, effective and safe agent for the prevention of AF …
with substantial associated cost. A low-cost, effective and safe agent for the prevention of AF …